Transforming genetic testing and personalized medicine

Our single method approach uses whole genome sequencing (WGS) to look at your entire DNA. It identifies all major types of genetic changes:


Small sequence changes

Structural Variants

Mitochondrial variants

Short tandem repeat expansions

Changing the Way Genetic Testing is Performed

Genetic variation is complex, yet traditional genetic testing methods focus on one or a few specific regions of DNA and one or a few types of variants. As a result, multiple rounds of testing are required to approximate a complete genomic picture.

Our method combines whole genome sequencing with in-silico analyses powered by proprietary algorithms to identify all major types of genetic changes with unparalleled sensitivity and specificity.

All from a single patient sample.

All summarized in a single clinical report.


Despite the label, rare diseases are not actually rare. With more than 7,000 rare diseases described, it’s estimated that greater than 30 million people in the US and greater than 350 million people globally are affected. Many of these diseases are genetic in origin. Patients and their families often go years without a diagnosis, pursuing one test after another in search of an explanation for their clinical symptoms.

Our Genomic Unity® testing program eliminates the need for iterative tests. By sequencing the patient’s entire DNA and analyzing all relevant variants we achieve:

Higher diagnostic yield   |  Faster time to diagnosis   |   Lower overall cost

We’re bringing an end to the diagnostic odyssey.

The right test for any patient

All patients in need of germline testing benefit from our testing methodology.

We sequence your patient’s entire DNA. Then we computationally isolate the relevant gene or genes for interpretation.

In addition to performing any of the tests listed in our menu, we can customize our analysis to a single gene or panel of genes. Because the patient’s entire DNA has already been sequenced, we can immediately reflex up to a comprehensive analysis of all genes if the initial analysis does not identify a causal variant.

The benefit to patients? Superior results in less time.

Please do not submit Protected Health Information (PHI) through this email address.

If you need to submit Protected Health Information (PHI), please call us at 617-209-2090 and we will work with you to submit the information through an alternate mechanism.

Otherwise, please continue: